×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MAIA – maia biotechnology, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MAIA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
08:13 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings [Yahoo! Finance]
12/24
08:01 am
maia
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Medium
Report
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
12/16
04:15 pm
maia
MAIA Biotechnology Announces $1.51 Million Private Placement
Medium
Report
MAIA Biotechnology Announces $1.51 Million Private Placement
12/11
01:45 pm
maia
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
Medium
Report
MAIA's Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates [Yahoo! Finance]
12/11
01:00 pm
maia
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
Medium
Report
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
12/11
09:14 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer [Yahoo! Finance]
12/11
09:00 am
maia
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
High
Report
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
12/11
08:27 am
maia
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
High
Report
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
08:19 am
maia
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: Smith Stan
Neutral
Report
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: Smith Stan
12/23
08:17 am
maia
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: CHAOUKI STEVEN M
Low
Report
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: CHAOUKI STEVEN M
12/23
08:15 am
maia
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: Louie Ngar Yee
Low
Report
Form 4 MAIA Biotechnology, Inc. For: Dec 22 Filed by: Louie Ngar Yee
12/17
06:02 am
maia
Form 8-K MAIA Biotechnology, Inc. For: Dec 16
Low
Report
Form 8-K MAIA Biotechnology, Inc. For: Dec 16
12/11
04:15 pm
maia
Form 8-K MAIA Biotechnology, Inc. For: Dec 11
High
Report
Form 8-K MAIA Biotechnology, Inc. For: Dec 11
12/10
04:16 pm
maia
Form 8-K MAIA Biotechnology, Inc. For: Dec 10
High
Report
Form 8-K MAIA Biotechnology, Inc. For: Dec 10
12/9
04:51 pm
maia
Form 4 MAIA Biotechnology, Inc. For: Dec 05 Filed by: Smith Stan
Medium
Report
Form 4 MAIA Biotechnology, Inc. For: Dec 05 Filed by: Smith Stan
12/4
04:05 pm
maia
Form SCHEDULE 13D/A MAIA Biotechnology, Inc. Filed by: Vitoc Vlad
Neutral
Report
Form SCHEDULE 13D/A MAIA Biotechnology, Inc. Filed by: Vitoc Vlad
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: